000078 海王生物
已收盘 07-14 15:00:00
资讯
新帖
简况
海王生物：本次控制权变更及向特定对象发行股票事项终止
证券之星 · 07-10
海王生物：本次控制权变更及向特定对象发行股票事项终止
千金藤素概念盘中拉升，海王生物涨2.93%
市场透视 · 07-04
千金藤素概念盘中拉升，海王生物涨2.93%
海王生物(000078.SZ)：HW130注射液完成I期临床试验
智通财经 · 07-03
海王生物(000078.SZ)：HW130注射液完成I期临床试验
异动快报：海王生物（000078）7月2日9点38分触及涨停板
证券之星 · 07-02
异动快报：海王生物（000078）7月2日9点38分触及涨停板
千金藤素概念盘中拉升，海王生物涨停
市场透视 · 07-02
千金藤素概念盘中拉升，海王生物涨停
仿制药一致性评价概念盘中拉升，海王生物涨8.50%
市场透视 · 07-02
仿制药一致性评价概念盘中拉升，海王生物涨8.50%
海王生物：深圳市恒溢资产管理有限公司、投资者等多家机构于6月27日调研我司
证券之星 · 06-30
海王生物：深圳市恒溢资产管理有限公司、投资者等多家机构于6月27日调研我司
每周股票复盘：海王生物（000078）为子公司提供担保及智慧物流园建设进展
证券之星 · 06-28
每周股票复盘：海王生物（000078）为子公司提供担保及智慧物流园建设进展
海王生物（000078）股东深圳海王集团股份有限公司质押6362.5万股，占总股本2.42%
证券之星 · 06-23
海王生物（000078）股东深圳海王集团股份有限公司质押6362.5万股，占总股本2.42%
海王生物易主终止背后：三年累亏39亿 负债率高企
市场资讯 · 06-21
海王生物易主终止背后：三年累亏39亿 负债率高企
每周股票复盘：海王生物（000078）控股股东质押股份数量达46.15%总股本
证券之星 · 06-14
每周股票复盘：海王生物（000078）控股股东质押股份数量达46.15%总股本
又一上市公司“卖壳”终止！海王生物2024年巨亏11亿，把交易压垮了？
市场资讯 · 06-08
又一上市公司“卖壳”终止！海王生物2024年巨亏11亿，把交易压垮了？
海王生物最新公告：终止控制权变更及向特定对象发行股票事项
证券之星 · 06-06
海王生物最新公告：终止控制权变更及向特定对象发行股票事项
异动快报：海王生物（000078）5月27日10点2分触及涨停板
证券之星 · 05-27
异动快报：海王生物（000078）5月27日10点2分触及涨停板
每周股票复盘：海王生物（000078）为多家子公司提供总计约48.35亿元担保
证券之星 · 05-24
每周股票复盘：海王生物（000078）为多家子公司提供总计约48.35亿元担保
海王生物收盘上涨1.70%，最新市净率3.46，总市值62.88亿元
金融界 · 05-19
海王生物收盘上涨1.70%，最新市净率3.46，总市值62.88亿元
海王生物收盘上涨1.76%，最新市净率3.34，总市值60.78亿元
金融界 · 05-06
海王生物收盘上涨1.76%，最新市净率3.34，总市值60.78亿元
图解海王生物一季报：第一季度单季净利润同比减44.38%
证券之星 · 04-28
图解海王生物一季报：第一季度单季净利润同比减44.38%
图解海王生物年报：第四季度单季净利润同比增30.30%
证券之星 · 04-28
图解海王生物年报：第四季度单季净利润同比增30.30%
海王生物最新公告：全资子公司收到NEP018片药物临床试验批准通知书
证券之星 · 03-10
海王生物最新公告：全资子公司收到NEP018片药物临床试验批准通知书
加载更多
公司概况
公司名称：
深圳市海王生物工程股份有限公司
所属行业：
零售业
上市日期：
1998-12-18
主营业务：
深圳市海王生物工程股份有限公司的主营业务是药品生产制造及流通、保健品及食品销售、医疗器械销售。公司的主要产品是药品流通、医疗器械、医药流通延伸供应链增值服务、医药工业、医药研发。2024年，公司荣获“大湾区TOP100企业”、“深圳500强企业”、“2023年度中国药品流通行业批发企业主营业务收入二十强榜单”等殊荣，在2023年中国药品流通批发企业主营业务收入百强榜单中位列第九名。
发行价格：
5.36
{"stockData":{"symbol":"000078","market":"SZ","secType":"STK","nameCN":"海王生物","latestPrice":2.67,"timestamp":1752476622000,"preClose":2.66,"halted":0,"volume":44321235,"delay":0,"changeRate":0.0038,"floatShares":2626000000,"shares":2631000000,"eps":-0.4608,"marketStatus":"已收盘","change":0.01,"latestTime":"07-14 15:00:00","open":2.66,"high":2.69,"low":2.62,"amount":118000000,"amplitude":0.0263,"askPrice":2.67,"askSize":4469,"bidPrice":2.66,"bidSize":8259,"shortable":0,"etf":0,"ttmEps":-0.4608,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752543000000},"marketStatusCode":5,"adr":0,"adjPreClose":2.66,"symbolType":"stock","openAndCloseTimeList":[[1752456600000,1752463800000],[1752469200000,1752476400000]],"highLimit":2.93,"lowLimit":2.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2631123257,"isCdr":false,"pbRate":3.85,"roa":"--","roe":"1.31%","epsLYR":-0.4536,"committee":-0.087173,"marketValue":7025000000,"turnoverRate":0.0169,"status":0,"floatMarketCap":7013000000},"requestUrl":"/m/hq/s/000078","defaultTab":"news","newsList":[{"id":"2550562874","title":"海王生物：本次控制权变更及向特定对象发行股票事项终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2550562874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550562874?lang=zh_cn&edition=full","pubTime":"2025-07-10 20:52","pubTimestamp":1752151977,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物07月10日在投资者关系平台上答复投资者关心的问题。海王星辰不在上市公司体系。本次控制权变更及向特定对象发行股票事项终止后，公司控股股东、实际控制人未发生变化，不会对公司正常经营与持续稳定发展造成不利影响。公司将根据相关事项进展情况，严格按照有关法律法规的规定和要求履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000036191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078","BK0209","BK0060","BK0028","BK0168","BK0188"],"gpt_icon":0},{"id":"2548334173","title":"千金藤素概念盘中拉升，海王生物涨2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548334173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548334173?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:40","pubTimestamp":1751593255,"startTime":"0","endTime":"0","summary":"07月04日，千金藤素概念盘中拉升，截至09点40分，千金藤素概念整体指数上涨0.62%，报1041.070点。从个股上来看，该概念的成分股中，海王生物涨2.93%，皓元医药、步长制药、优宁维涨幅居前。从资金上来看，截止发稿，千金藤素概念主力净流入为17.41万，其中皓元医药受到资金热捧，主力净流入513.06万；拉长时间线来看，该板块近20日主力资金净流入-5.58亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094055979946f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094055979946f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0196","BK0209","BK0188","BK0239","BK0060","000078","603858","BK0168","688131"],"gpt_icon":0},{"id":"2548876434","title":"海王生物(000078.SZ)：HW130注射液完成I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2548876434","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548876434?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:18","pubTimestamp":1751530683,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王生物 发布公告，公司全资子公司深圳海王医药科技研究院有限公司研发的HW130注射液已于近日完成I期临床试验，并取得I期临床研究报告。结果表明，HW130注射液具有较好的安全性和耐受性，研究中未发生导致永久停药或提前退出试验的与研究药物相关的不良事件，未发生导致死亡的不良事件。HW130注射液I期临床试验达到预期目的，为后续临床试验探索提供了充分依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0168","BK0060","BK0188","BK1141","BK1576","000078","03347","BK0028","BK1583","BK0209"],"gpt_icon":0},{"id":"2548414832","title":"异动快报：海王生物（000078）7月2日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2548414832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548414832?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:40","pubTimestamp":1751420437,"startTime":"0","endTime":"0","summary":"证券之星7月2日盘中消息，9点38分海王生物触及涨停板。目前价格2.72，上涨10.12%。其所属行业医药商业目前上涨。领涨股为塞力医疗。该股为医药，中药，医药商业概念热股，当日医药概念上涨0.3%，中药概念上涨0.21%，医药商业概念上涨0.16%。7月1日的资金流向数据方面，主力资金净流入161.48万元，占总成交额2.36%，游资资金净流出201.17万元，占总成交额2.93%，散户资金净流入39.69万元，占总成交额0.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200008641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0168","BK0060","000078","BK0028","BK0209"],"gpt_icon":0},{"id":"2548832248","title":"千金藤素概念盘中拉升，海王生物涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548832248?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:39","pubTimestamp":1751420389,"startTime":"0","endTime":"0","summary":"07月02日，千金藤素概念盘中拉升，截至09点39分，千金藤素概念整体指数上涨1.06%，报1030.590点。从个股上来看，该概念的成分股中，海王生物涨停，方盛制药、步长制药涨幅居前。从资金上来看，截止发稿，千金藤素概念主力净流入为2516.34万，其中海王生物受到资金热捧，主力净流入3258.47万；拉长时间线来看，该板块近20日主力资金净流入-6.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020939499796a20e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020939499796a20e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0239","000078","BK0060","603998","BK0168","603858","BK0209","BK0028"],"gpt_icon":0},{"id":"2548883221","title":"仿制药一致性评价概念盘中拉升，海王生物涨8.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883221?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:35","pubTimestamp":1751420126,"startTime":"0","endTime":"0","summary":"07月02日，仿制药一致性评价概念盘中拉升，截至09点35分，仿制药一致性评价概念整体指数上涨0.65%，报1098.790点。从个股上来看，该概念的成分股中，海王生物涨8.50%，南新制药、乐普医疗等3只股涨幅超过5%。从资金上来看，截止发稿，仿制药一致性评价概念主力净流入为-2038.41万，其中乐普医疗受到资金热捧，主力净流入6250.61万；拉长时间线来看，该板块近20日主力资金净流入-92.24亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093526a72967bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093526a72967bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0060","BK0168","BK0239","688189","BK0209","000078"],"gpt_icon":0},{"id":"2547039698","title":"海王生物：深圳市恒溢资产管理有限公司、投资者等多家机构于6月27日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2547039698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547039698?lang=zh_cn&edition=full","pubTime":"2025-06-30 09:10","pubTimestamp":1751245813,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年6月27日海王生物发布公告称深圳市恒溢资产管理有限公司、投资者、深圳市金田私募证券基金管理有限公司、深圳同裕泉私募证券基金管理有限公司、深圳市大秦基金管理有限公司、冠通期货股份有限公司深圳分公司、深圳市优美利投资管理有限公司、深圳市瑞兆资产管理有限公司、深圳恒益天泽资本管理有限公司、深圳前海汇成咨询服务有限公司于2025年6月27日调研我司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000002546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1258","BK0168","000078","BK0028","BK0060","BK0188","BK0209","09983","BK1583","BK1229","BK1542"],"gpt_icon":0},{"id":"2547803709","title":"每周股票复盘：海王生物（000078）为子公司提供担保及智慧物流园建设进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2547803709","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547803709?lang=zh_cn&edition=full","pubTime":"2025-06-29 04:08","pubTimestamp":1751141292,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘，海王生物报收于2.42元，较上周的2.37元上涨2.11%。本周，海王生物6月27日盘中最高价报2.45元。本周关注点公司公告汇总：海王生物为多家控股子公司提供总计约1.7亿元的担保。公司公告汇总：全资子公司山东海王银河医药有限公司签署智慧医药物流园项目一期工程施工合同，总投资额达13450万元。截至目前，本公司累计担保余额约为人民币4810亿元，约占公司2024年度经审计合并报表净资产的比例为169.15%，不存在逾期担保的情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900000709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","BK0168","000078","BK0209"],"gpt_icon":0},{"id":"2545413437","title":"海王生物（000078）股东深圳海王集团股份有限公司质押6362.5万股，占总股本2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545413437","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545413437?lang=zh_cn&edition=full","pubTime":"2025-06-23 18:31","pubTimestamp":1750674716,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物6月23日公开信息显示，股东深圳海王集团股份有限公司向中信银行股份有限公司深圳分行合计质押6362.5万股，占总股本2.42%。质押详情见下表：截止本公告日，股东深圳海王集团股份有限公司已累计质押股份12.14亿股，占其持股总数的99.83%。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300024565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0188","000078","BK0060","BK0209","BK0028"],"gpt_icon":0},{"id":"2545643855","title":"海王生物易主终止背后：三年累亏39亿 负债率高企","url":"https://stock-news.laohu8.com/highlight/detail?id=2545643855","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545643855?lang=zh_cn&edition=full","pubTime":"2025-06-22 04:50","pubTimestamp":1750539000,"startTime":"0","endTime":"0","summary":" 近期，海王生物一纸公告宣告与广东省丝绸纺织集团及控股股东深圳海王集团签署解除协议，终止筹划三年之久的控制权变更事项。同时，公司决定终止向特定对象发行A股股票计划。彼时，海王生物首次公告称拟筹划重大资产重组及控股股东筹划混合所有制改革事项，点燃市场对国资入主纾困的期待。 截至2025年3月末，海王生物的资产负债率攀升至89.76%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-22/doc-infaxaat0876417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0168","BK0028","BK0209","BK0060","000078"],"gpt_icon":0},{"id":"2543635016","title":"每周股票复盘：海王生物（000078）控股股东质押股份数量达46.15%总股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2543635016","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543635016?lang=zh_cn&edition=full","pubTime":"2025-06-14 15:15","pubTimestamp":1749885314,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，海王生物报收于2.51元，较上周的2.56元下跌1.95%。本周，海王生物6月11日盘中最高价报2.75元。本次解除质押股份数量为111,500,000股，占其所持股份比例9.17%，占公司总股本比例4.24%，质权人为中国光大银行股份有限公司深圳分行。截至公告披露日，海王集团持股数量为1,216,445,128股，持股比例46.23%，本次解押及质押后质押股份数量仍为1,214,318,878股，占其所持股份比例99.83%，占公司总股本比例46.15%。海王集团股份质押为融资增信需要，不存在兑付及平仓风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400013377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078","BK0209","BK0060","BK0028","BK0168","BK0188"],"gpt_icon":0},{"id":"2541236978","title":"又一上市公司“卖壳”终止！海王生物2024年巨亏11亿，把交易压垮了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2541236978","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541236978?lang=zh_cn&edition=full","pubTime":"2025-06-08 21:01","pubTimestamp":1749387660,"startTime":"0","endTime":"0","summary":" 2025年6月6日，海王生物披露《关于终止控制权变更及向特定对象发行股票事项的公告》，海王生物控股权“卖壳”终止了。 海王生物控制权变更公告可追溯至2024年1月。 但根据近期海辰生物2024年年度报告披露，2024年度海王生物再次亏损11亿。海王生物于2025年第一季度进一步亏损7，400万，相比去年大幅下滑。 公司将部分融资费用、补偿款支出计入销售费用，导致相关费用列报不准确；部分销售费用确认跨期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-06-08/doc-inezkqcy7336540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000078","BK0209","BK0060","BK0028","BK0168","BK0188"],"gpt_icon":0},{"id":"2541856723","title":"海王生物最新公告：终止控制权变更及向特定对象发行股票事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2541856723","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541856723?lang=zh_cn&edition=full","pubTime":"2025-06-06 18:20","pubTimestamp":1749205213,"startTime":"0","endTime":"0","summary":"海王生物(000078.SZ)公告称，公司、海王集团及丝纺集团签署了合作协议书解除协议，终止控制权变更事项。同时，丝纺集团与海王集团及其一致行动人签署了股份转让协议及表决权放弃协议解除协议。本次控制权变更事项终止。此外，公司与广新集团及丝纺集团签署了股份认购协议解除协议，终止向特定对象发行股票事项。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600030643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078","BK0168","BK0188","BK0028","BK0060","BK0209"],"gpt_icon":0},{"id":"2538487588","title":"异动快报：海王生物（000078）5月27日10点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2538487588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538487588?lang=zh_cn&edition=full","pubTime":"2025-05-27 10:05","pubTimestamp":1748311533,"startTime":"0","endTime":"0","summary":"证券之星5月27日盘中消息，10点2分海王生物触及涨停板。目前价格2.57，上涨9.83%。其所属行业医药商业目前上涨。领涨股为浙江震元。该股为创新药，中药，医药概念热股，当日创新药概念上涨1.38%，中药概念上涨1.33%，医药概念上涨1.16%。5月26日的资金流向数据方面，主力资金净流出564.67万元，占总成交额13.25%，游资资金净流入343.45万元，占总成交额8.06%，散户资金净流入221.22万元，占总成交额5.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052700008617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","000078","BK0060","BK0209","BK0028","BK0188"],"gpt_icon":0},{"id":"2537673601","title":"每周股票复盘：海王生物（000078）为多家子公司提供总计约48.35亿元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2537673601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537673601?lang=zh_cn&edition=full","pubTime":"2025-05-24 14:41","pubTimestamp":1748068868,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘，海王生物报收于2.36元，较上周的2.35元上涨0.43%。本周，海王生物5月21日盘中最高价报2.44元。海王生物当前最新总市值62.09亿元，在医药商业板块市值排名15/31，在两市A股市值排名2371/5148。截至目前，公司累计担保余额约为人民币48.35亿元，占公司2024年度经审计合并报表净资产的比例为170.03%，不存在逾期担保的情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400012675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0209","BK0188","BK0028","BK0168","000078"],"gpt_icon":0},{"id":"2536082415","title":"海王生物收盘上涨1.70%，最新市净率3.46，总市值62.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536082415","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536082415?lang=zh_cn&edition=full","pubTime":"2025-05-19 16:08","pubTimestamp":1747642132,"startTime":"0","endTime":"0","summary":"5月19日，海王生物今日收盘2.39元，上涨1.70%，最新市净率3.46，创29天以来新低，总市值62.88亿元。股东方面，截至2025年3月31日，海王生物股东户数126898户，较上次减少2835户，户均持股市值35.28万元，户均持股数量2.76万股。深圳市海王生物工程股份有限公司的主营业务是药品生产制造及流通、保健品及食品销售、医疗器械销售。最新一期业绩显示，2025年一季报，公司实现营业收入73.76亿元，同比-8.81%；净利润2371.58万元，同比-44.38%，销售毛利率9.23%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/19160850493814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","BK0209","BK0060","000078","BK0028","BK0168"],"gpt_icon":0},{"id":"2533396573","title":"海王生物收盘上涨1.76%，最新市净率3.34，总市值60.78亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533396573","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533396573?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:10","pubTimestamp":1746519044,"startTime":"0","endTime":"0","summary":"5月6日，海王生物今日收盘2.31元，上涨1.76%，最新市净率3.34，创14天以来新低，总市值60.78亿元。截至2025年一季报，共有2家机构持仓海王生物，其中其他2家，合计持股数123022.47万股，持股市值29.16亿元。深圳市海王生物工程股份有限公司主营业务是生物制品、生化制品、海洋药物、海洋生物制品、中成药的生产销售。最新一期业绩显示，2025年一季报，公司实现营业收入73.76亿元，同比-8.81%；净利润2371.58万元，同比-44.38%，销售毛利率9.23%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/06161050155097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0060","BK0209","BK0168","000078","BK0188","BK0028"],"gpt_icon":0},{"id":"2531266837","title":"图解海王生物一季报：第一季度单季净利润同比减44.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266837","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531266837?lang=zh_cn&edition=full","pubTime":"2025-04-29 04:36","pubTimestamp":1745872577,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物2025年一季报显示，公司主营收入73.76亿元，同比下降8.81%；归母净利润2371.58万元，同比下降44.38%；扣非净利润-7474.36万元，同比下降257.78%；负债率89.76%，投资收益9529.6万元，财务费用1.5亿元，毛利率9.23%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900002225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078"],"gpt_icon":0},{"id":"2531066253","title":"图解海王生物年报：第四季度单季净利润同比增30.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531066253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531066253?lang=zh_cn&edition=full","pubTime":"2025-04-29 01:31","pubTimestamp":1745861496,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物2024年年报显示，公司主营收入303.17亿元，同比下降16.75%；归母净利润-11.93亿元，同比上升29.38%；扣非净利润-12.38亿元，同比上升28.87%；其中2024年第四季度，公司单季度主营收入57.65亿元，同比下降25.89%；单季度归母净利润-12.4亿元，同比上升30.3%；单季度扣非净利润-12.58亿元，同比上升29.46%；负债率90.13%，投资收益1114.7万元，财务费用8.06亿元，毛利率9.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900000776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078"],"gpt_icon":0},{"id":"2518784211","title":"海王生物最新公告：全资子公司收到NEP018片药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2518784211","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518784211?lang=zh_cn&edition=full","pubTime":"2025-03-10 17:00","pubTimestamp":1741597216,"startTime":"0","endTime":"0","summary":"海王生物(000078.SZ)公告称，公司全资子公司海王医药研究院近日收到国家药监局核准签发的《药物临床试验批准通知书》，同意NEP018片单药在晚期恶性实体瘤中开展临床试验。NEP018片是海王医药研究院自主研发的新型肿瘤靶向小分子激酶抑制剂，对胃肠道肿瘤具有良好的抑制作用。但新药研发过程周期长、环节多，存在技术、审核等多种不确定因素的影响，预计短期内对公司经营业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031000022377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","03347","BK0188","BK0209","BK1583","BK0028","BK0168","BK1576","BK1141","000078"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752540191508,"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0637},{"period":"3month","weight":0.1558},{"period":"6month","weight":0.068},{"period":"1year","weight":0.2248},{"period":"ytd","weight":0.0471}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0422},{"period":"3month","weight":0.0771},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1846},{"period":"ytd","weight":0.0501}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳市海王生物工程股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"126898人(较上一季度减少2.19%)","perCapita":"20697股","listingDate":"1998-12-18","address":"广东省深圳市南山区科技中三路1号海王银河科技大厦24层","registeredCapital":"263112万元","survey":" 深圳市海王生物工程股份有限公司的主营业务是药品生产制造及流通、保健品及食品销售、医疗器械销售。公司的主要产品是药品流通、医疗器械、医药流通延伸供应链增值服务、医药工业、医药研发。2024年，公司荣获“大湾区TOP100企业”、“深圳500强企业”、“2023年度中国药品流通行业批发企业主营业务收入二十强榜单”等殊荣，在2023年中国药品流通批发企业主营业务收入百强榜单中位列第九名。","listedPrice":5.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海王生物(000078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海王生物,000078,海王生物股票,海王生物股票老虎,海王生物股票老虎国际,海王生物行情,海王生物股票行情,海王生物股价,海王生物股市,海王生物股票价格,海王生物股票交易,海王生物股票购买,海王生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海王生物(000078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}